Pharmanutra

Report Publication Announcement • Jan 29, 2021

SPAFID

Informazione Regolamentata n. 20106-4-2021		Data/Ora Ricezione 29 Gennaio 2021 08:04:05	MTA - Star
Societa'	:	Pharmanutra S.p.A.
Identificativo Informazione Regolamentata	:	141936
Nome utilizzatore	:		PHARMANUTRAN02 - Lacorte Roberto
Tipologia	:	REGEM
Data/Ora Ricezione	:	29 Gennaio 2021 08:04:05
Data/Ora Inizio Diffusione presunta	:	29 Gennaio 2021 08:04:06
Oggetto	:	PR PHN - corporate events 2021 29_01_2021
Testo del comunicato

Vedi allegato.

PHARMANUTRA S.P.A.: PUBLICATION OF THE 2021 CORPORATE EVENTS CALENDAR

Pisa, 29TH January 2021 - PharmaNutra S.p.A. (the "Company") announces the dates for the examination of the financial results of the Company by the Board of Directors and the Shareholders' Meeting:

Date	Event
March 25th, 2021	Board of Directors for the examination of the Financial Statements as of 31st December 2020
April 26th, 2021	Ordinary Shareholders' Meeting for the approval of the Financial Statements as of 31st December 2020
May 10th	Board of Directors Meeting for the approval of the Interim Management
, 2021	Statements as of 31st March 2021
September 6th	Board of Directors Meeting for the approval of the Half-Yearly Report as of
, 2021	30th June 2021
November 8th	Board of Directors Meeting for the approval of the Interim Management
, 2021	Statements as of 30th September 2021

Any amendments to the above calendar will be notified to the market timely.

PharmaNutra S.p.A.

Founded and led by the President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra was established in 2003. It develops unique nutritional supplements and innovative nutritional devices, handling the entire production process, from proprietary raw materials to finished product. The effectiveness of its products is documented by considerable scientific proof. The Group distributes and sells its products in Italy and abroad. In Italy, products are sold through a network of approximately 130 Pharmaceutical Representatives serving doctors and also exclusively selling PharmaNutra products to pharmacies throughout Italy. Products are sold in 50 countries abroad, through 32 partners selected from among the finest pharmaceutical companies. Over the years, PharmaNutra has stood out in the production of iron-based nutritional supplements with the trademark SiderAL®, where it can claim important Sucrosomial Technology® patents. The Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence. PharmaNutra.it

For further information:

Via Delle Lenze, 216/b - 56122 Pisa Tel. +39 050 7846500 investorrelation@pharmanutra.it

Internal Press Office press@calabughi.com

PharmaNutra S.p.A. Press Office - Spriano Communication & Partners

Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708

Matteo Russo mrusso@sprianocommunication.com Cristina Tronconi ctronconi@sprianocommunication.com